We proceeded with exploiting this hypothesis pharmacologically and show that Roc-A, a natural anticancer compound known to bind to PHB1 and PHB2 directly31, indeed appears to interfere with cancer cell migration in a wound healing and directional migration assay, both, even at low concentrations (25 to 100 nM). Here, PHB2 is linked to cancer.